BIOCON BIOLOGICS GLOBAL PLC
Get an alert when BIOCON BIOLOGICS GLOBAL PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£138
USD 183
Latest balance sheet
Net assets
£2k
USD 2,617
Equity attributable
Employees
0
Average over period
Profit before tax
£1.4k
USD 1,863
Period ending 2026-03-31
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £34,333 | £32,119 | — | |
| Operating profit | £621 | £634 | — | |
| Profit before tax | £1,130 | £1,409 | — | |
| Net profit | £847 | £1,049 | — | |
| Cash | £65 | £138 | — | |
| Total assets less current liabilities | £574,151 | £1,979 | — | |
| Net assets | — | £1,979 | — | |
| Equity | £951 | £1,979 | — | |
| Average employees | — | 0 | — | |
| Wages | — | — | — | |
| Directors' remuneration | — | — | — |
Figures converted to GBP from USD at 0.756 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing covers about 12 months versus 9 months prior. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating margin | 1.8% | 2.0% | |
| Net margin | 2.5% | 3.3% | |
| Return on capital employed | 0.1% | 32.0% | |
| Gearing (liabilities / total assets) | — | 2.1% | |
| Current ratio | 0.83x | 47.02x | |
| Interest cover | 0.03x | 0.02x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KNAV Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Notwithstanding this, given the Company's net asset position and cash reserves, the directors are satisfied that it has sufficient funds to meet its remaining liabilities as they fall due.”
Significant events
- “On 26 March 2026, the Board of Directors approved, pursuant to Business Transfer Agreement (BTA), the transfer of business and assets of the Company to a fellow subsidiary, Biocon Biologics UK Plc, for a total cash consideration of USD 2.3 Million, with effect from 1 November 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ELEMENTAL COMPANY SECRETARY LIMITED | Corporate Secretary | 2024-07-19 | — | — |
| JATAR, Rajendra | Director | 2024-07-19 | Nov 1966 | Irish |
| UPADHYE, Kedar Narayan | Director | 2025-11-04 | Jul 1977 | Indian |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HAGGAR, Nicholas Robert | Director | 2024-07-19 | 2025-01-28 |
| WALLS, John Russell Fotheringham | Director | 2024-07-19 | 2025-11-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Biocon Biologics International Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-07-19 | Active |
Filing timeline
Last 17 of 17 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-10-14 MA Memorandum articles
- 2024-10-14 RESOLUTIONS Resolution
- 2024-09-06 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-09 | AA | accounts | Accounts with accounts type full | |
| 2026-07-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-06-25 | CH01 | officers | Change person director company with change date | |
| 2025-11-13 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-24 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-09 | AA | accounts | Accounts with accounts type full | |
| 2025-07-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-02-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-14 | MA | incorporation | Memorandum articles | |
| 2024-10-14 | RESOLUTIONS | resolution | Resolution | |
| 2024-09-06 | RESOLUTIONS | resolution | Resolution | |
| 2024-09-06 | CERT8A | incorporation | Legacy | |
| 2024-09-06 | AA01 | accounts | Change account reference date company current shortened | |
| 2024-09-06 | SH50 | reregistration | Application trading certificate | |
| 2024-09-02 | SH01 | capital | Capital allotment shares | |
| 2024-07-19 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Spotted an error, or named here and want to reply? Report it · How we handle corrections